DPT Laboratories
San Antonio, TX
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (5)
○ EMA GMP
○ MHRA GMP
Quick Facts: DPT Laboratories
- Signal Score
- 60.0/100
- Quality Compliance
- Assessment pending
- Headquarters
- San Antonio, TX
- Modalities
- Semi-solid (creams, ointments, gels, lotions), Sterile semi-solids, Liquids, Aerosols
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About DPT Laboratories
Auto-created by AI matchmaker. Data verification pending.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesSemi-solid (creams, ointments, gels, lotions), Sterile semi-solids, Liquids, Aerosols
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
60.0
Broad modality coverage (4 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press5 articles
Broad modality coverage (4 modalities)
Recent News 5 articles
DPT Laboratories names Kuljit Bhatia Vice President of Research & Development - Contract Pharma
CEO Insights: Industry Trends Driving Strong Tailwinds for U.S.-based CDMOs - Contract Pharma
CEO Spotlight: Paul Josephs - Contract Pharma
Semi-Solid Dosage Contract Manufacturing Market Size to Hit USD 61.81 Bn by 2035 - Precedence Research
Mylan gets topicals CDMO as part of $1B deal for skin products - Fierce Pharma
Frequently Asked Questions About DPT Laboratories
What is DPT Laboratories's CDMO Signal Score?
DPT Laboratories has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating DPT Laboratories for a manufacturing program?
Use the free AI matchmaker to compare DPT Laboratories against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.